NCT04144387: IFM2017 Evaluation of the Impact of the Update SMM Criteria on the Natural History SMM
Updated: May 23, 2022
IFM 2017-04 - CARRISMM
NCT04144387: Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. (CARRISMM)
IFM 2017-04
CARRISMM IFM 2017-04
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. (CARRISMM)
This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.
Sponsor:
Intergroupe Francophone du Myelome
ClinicalTrials.gov Identifier: NCT04144387
Official Title: Evaluation of the Impact of the Update Multiple Myeloma Criteria on the Natural History of Smoldering Myeloma in Order to Establish New Recommendations About Follow-up and Prognostic Evaluation of Smoldering Myeloma (CARRISMM)
First Posted: October 30, 2019
Click here to see details on ClinicalTrials.gov
Procedure: Myelogram
Locations
Europe
Belgium
France
Monaco